Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bourcier

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
The Journal of Rheumatology|June 13, 2017
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily PracticeDafna D Gladman, Yves Poulin, Karen Adams, et al.
Experimental Dermatology|April 2, 2015
Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasisKristian Reich, Kim A Papp, Robert T Matheson, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
Experimental Dermatology|September 13, 2017
Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)Ali Mehdizadeh, Afsaneh Alavi, Raed Alhusayen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
The Journal of Rheumatology|June 13, 2017
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily PracticeDafna D Gladman, Yves Poulin, Karen Adams, et al.
Experimental Dermatology|April 2, 2015
Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasisKristian Reich, Kim A Papp, Robert T Matheson, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
Experimental Dermatology|September 13, 2017
Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)Ali Mehdizadeh, Afsaneh Alavi, Raed Alhusayen, et al.
Pageof 4